M
101.20
-0.48 (-0.47%)
| Previous Close | 101.68 |
| Open | 101.64 |
| Volume | 279,401 |
| Avg. Volume (3M) | 419,451 |
| Market Cap | 5,897,874,944 |
| Price / Earnings (TTM) | 49.37 |
| Price / Earnings (Forward) | 27.47 |
| Price / Sales | 4.62 |
| Price / Book | 4.58 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2024 |
| Profit Margin | 9.05% |
| Operating Margin (TTM) | 10.99% |
| Diluted EPS (TTM) | 2.05 |
| Quarterly Revenue Growth (YOY) | 7.80% |
| Quarterly Earnings Growth (YOY) | 10.10% |
| Total Debt/Equity (MRQ) | 61.90% |
| Current Ratio (MRQ) | 5.36 |
| Operating Cash Flow (TTM) | 214.31 M |
| Levered Free Cash Flow (TTM) | 162.97 M |
| Return on Assets (TTM) | 4.55% |
| Return on Equity (TTM) | 9.40% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Merit Medical Systems, Inc. | Bearish | Bullish |
Stockmoo Score
1.4
| Analyst Consensus | 1.0 |
| Insider Activity | -2.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 4.0 |
| Average | 1.40 |
|
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 2.47% |
| % Held by Institutions | 104.17% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 114.00 (Barrington Research, 12.65%) | Buy |
| Median | 109.00 (7.71%) | |
| Low | 103.00 (B of A Securities, 1.78%) | Hold |
| 103.00 (Wells Fargo, 1.78%) | Hold | |
| Average | 108.00 (6.72%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 98.79 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 31 Oct 2024 | 109.00 (7.71%) | Buy | 98.66 |
| Barrington Research | 31 Oct 2024 | 114.00 (12.65%) | Buy | 98.66 |
| 18 Oct 2024 | 114.00 (12.65%) | Buy | 96.48 | |
| Needham | 31 Oct 2024 | 109.00 (7.71%) | Buy | 98.66 |
| 17 Sep 2024 | 109.00 (7.71%) | Buy | 98.51 | |
| B of A Securities | 16 Sep 2024 | 103.00 (1.78%) | Hold | 99.64 |
| Wells Fargo | 16 Sep 2024 | 103.00 (1.78%) | Hold | 99.64 |
| Piper Sandler | 09 Sep 2024 | 110.00 (8.70%) | Buy | 97.46 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MILLNER F. ANN | - | 101.83 | -12,500 | -1,272,875 |
| PARRA RAUL JR. | - | 101.97 | -5,361 | -546,661 |
| Aggregate Net Quantity | -17,861 | |||
| Aggregate Net Value ($) | -1,819,536 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 101.90 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MILLNER F. ANN | Director | 15 Nov 2024 | Automatic sell (-) | 12,500 | 101.83 | 1,272,875 |
| MILLNER F. ANN | Director | 15 Nov 2024 | Option execute | 12,500 | - | - |
| PARRA RAUL JR. | Officer | 07 Nov 2024 | Sell (-) | 5,361 | 101.97 | 546,661 |
| PARRA RAUL JR. | Officer | 07 Nov 2024 | Option execute | 5,361 | - | - |
| Date | Type | Details |
|---|---|---|
| 01 Nov 2024 | Announcement | Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical |
| 30 Oct 2024 | Announcement | Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance |
| 08 Oct 2024 | Announcement | Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 |
| 17 Sep 2024 | Announcement | Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical |
| 16 Sep 2024 | Announcement | Merit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients |
| 11 Sep 2024 | Announcement | Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |